Origin of Randall's Plaque
Randall's plaque originates in the basement membranes of the ascending thin limbs of the loop of Henle, then spreads through the renal interstitium to beneath the urothelium, where it serves as an attachment site for calcium oxalate stone formation 1, 2.
Anatomical Origin and Pathogenesis
The formation of Randall's plaque follows a specific anatomical pathway:
- Initial site: Calcium phosphate (apatite) deposits begin specifically in the basement membranes of the ascending thin limbs of the loop of Henle, not the descending limbs 1, 2
- Progression: The plaque spreads from these basement membranes through the interstitium toward the papillary surface 2, 3
- Surface breach: Eventually reaches and penetrates beneath the urothelium, where it becomes exposed to urine and serves as a nidus for calcium oxalate stone overgrowth 3, 4
Why Ascending Thin Limbs?
The preferential formation in ascending thin limbs (confirmed by ClC-Ka staining, not aquaporin 1) supports the "vas washdown" theory 1. This mechanism involves:
- Enhanced calcium delivery from the proximal tubule in stone formers
- Increased calcium reabsorption from the thick ascending limb into the interstitium
- Calcium transport via descending vasa recta into the deep medulla
- Elevated calcium supersaturation near ascending thin limbs, which do not reabsorb water, creating ideal conditions for crystal deposition 1
Composition and Cellular Mechanisms
Randall's plaque consists of calcium phosphate (primarily apatite) crystals mixed with organic matrix 3, 5. The formation involves:
- Cellular transformation: Renal epithelial cells undergo de-differentiation into an osteoblastic phenotype 6
- Inflammatory response: Pro-inflammatory M1 macrophages predominate around plaques, with downregulation of anti-inflammatory M2 macrophages 5
- Matrix production: Increased osteopontin, reduced crystallization inhibitors (fetuin, matrix Gla protein), and creation of matrix vesicles that support crystal nucleation 6, 5
Unexpected Finding
Recent evidence identified monosodium urate crystals intercalated within Randall's plaques in a subset of patients (3.4%), suggesting alternative formation mechanisms driven by systemic hyperuricemia rather than urinary supersaturation alone 4, 7.
Clinical Implications
Treatments that increase proximal tubule calcium reabsorption—such as low-sodium diets or thiazide diuretics—may reduce plaque formation and subsequent calcium stone development 1.
The guideline acknowledges Randall's plaques as a benign finding during hematuria evaluation that does not require intervention when non-obstructing stones are present 8. However, understanding plaque pathogenesis remains critical for stone prevention strategies.
Key Distinction
Plaque formation is specific to idiopathic calcium stone formers—patients with stones from other etiologies (such as obesity-related bypass surgery) form intratubular crystals in collecting ducts instead, not interstitial plaques 2, 9.